Our present study uncovered, in both endothelial cells and tumor cells, a unique mechanism of action showing that a direct interaction of EMMPRIN with VEGFR-2 on the plasma membrane is required for VEGF-induced VEGFR-2 activation and downstream signaling. Here, VEGFA is linked to neoplasm.